The U.S. Supreme Court on Tuesday denied certiorari review in a high-profile case involving the suicide of a Reed Smith partner in 2010, an outcome that favors GlaxoSmithKline, the pharmaceutical company whose antidepressant drug was targeted as a cause of his death.
In 2017, a Chicago federal jury awarded $3 million to the widow of lawyer Stewart Dolin after finding that GlaxoSmithKline was liable for his suicide. He was taking a generic version of the company’s drug Paxil.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]